What Is a ‘Tolerable’ Dose? AACR-Industry Roundtable 2025 Examines Dose Optimization
Experts discussed challenges and opportunities for dose optimization of cancer treatments at the 2025 AACR-Industry Roundtable.
Category: Meetings
Experts discussed challenges and opportunities for dose optimization of cancer treatments at the 2025 AACR-Industry Roundtable.
Shawn Lee, MD, PhD, an AACR-St. Baldrick’s Foundation Grantee, is working to personalize therapies for children with acute lymphoblastic...
Laura M. Heiser, PhD, and Mara H. Sherman, PhD share insights on cancer evolution as they preview an upcoming...
Promising early-phase clinical trial data were presented at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics.
Since 1993, the American Association for Cancer Research (AACR) has invested more than $542 million in grants to sustain...
Frontiers in Cancer Science 2025 cochairs, Soo Chin Lee and Reshma Taneja, preview this international cancer conference in Singapore.
The AACR Conference on the Science of Cancer Health Disparities explored the field's evolving landscape, including funding and and...
Frank McCormick, PhD, FAACR, reflected on a career chasing the notorious RAS oncogene that earned him the inaugural Stephenson...
The psychological toll of cancer can have an impact on patients’ mental health and put them at an increased...
The opening session from the AACR Science of Cancer Health Disparities conference highlighted how perseverance and adversity have informed...